William Demant Group opened a new Software R&D office in Poland

    William Demant Group, one of the largest medtech companies in the world, has invested in the Polish market and is expanding their Research & Development division in Warsaw. At the new location, the company will focus on software development for hearing healthcare products and thus create dozens of jobs for IT specialists and engineers. Demant Technology Centre opened its new office on the 16th of September 2016 in the prestigious Q22 office building. The number of R&D centers in Poland, strategically significant for large international companies, has been increasing over the past years. Numerous rankings outline the positives of Poland’s macroeconomic environment, indicating it as a popular country for setting up business operations. Modern infrastructure, firm politics, the economic system and an increasing number of highly qualified specialists all attract international investments. According to a report by Deloitte, the availability of a qualified and experienced workforce is quoted as the second most important factor influencing the level of R&D spending. This may result in stronger collaboration between the scientific and the business worlds[1]. “Poland has a great R&D investment potential thanks to its modern R&D infrastructure and access to well-qualified and talented specialists. In William Demant, we consider a strong R&D set-up as a core element of the business and thus a mean to further develop our position as a leading hearing healthcare company that makes a life-changing difference to people suffering from hearing loss,” said Søren Nielsen, COO (Deputy CEO), William Demant Holding A/S and President, Oticon A/S. “With our new set-up in Warsaw, we are able to meet a fast growing need for more and more specialist in software development while also securing an optimal R&D output in a competitive way. We want to create a location where skilled and experienced specialists develop  state-of-the-art innovations  that can reach and help even more people worldwide,” he added. Expanding R&D and opening a new office in Warsaw is part of the implementation of William Demant’s global R&D strategy. Demant Technology Centre will create many jobs for IT specialists and engineers, primarily software developers and programmers. This prestigious location of Q22 office building also house other companies of the William Demant Group, e.g. Oticon Polska. *** William Demant Group is a leading global hearing healthcare company that develops, manufactures and sells hearing instruments, hearing implants, diagnostic instruments and personal communication devices. The group is behind the commercial successes of world-renowned brands such as Oticon, Bernafon, Sonic, Oticon Medical, Interacoustics. William Demant operates in a global market with companies in more than 30 countries, a total staff exceeding 11 000. The group sells products in more than 130 countries. [1] Poland Corporate R&D Report 2016, Deloitte, source: http://www2.deloitte.com/pl/pl/pages/zarzadzania-procesami-i-strategiczne/articles/innowacje/badania-i-rozwoj-w-przedsiebiorstwach-2016-raport.html Accessed: August 2016